- ScreenPro Security (SCRN) has closed a non-brokered private placement for gross proceeds of $915,000
- The company issued 9,700,000 units at $0.05 per unit and 8,600,000 common shares at $0.05 per share
- The gross proceeds will be used to support revenue growth
- ScreenPro is a medical technology company
- ScreenPro (SCRN) opened trading at C$0.02
ScreenPro Security (SCRN) has closed its previously announced non-brokered private placement for gross proceeds of $915,000.
The company issued 9,700,000 units at $0.05 per unit and 8,600,000 common shares at $0.05 per share. Each unit consists of one common share and one common share purchase warrant. Each warrant will entitle the holder to acquire one additional share at a price of $0.05 for a period of eighteen months.
The gross proceeds will be used for general working capital to support revenue growth and for general corporate purposes.
ScreenPro paid cash commissions totalling $1,200.
All securities issued are subject to a statutory four-month hold period.
ScreenPro is a medical technology company that provides turnkey screening solutions with its proprietary medical alerting software. ScreenPro also recently introduced Naturevan Nutrition Ltd. to its portfolio, providing vitamins and supplements that are made in Canada and distributed for sale online.
ScreenPro (SCRN) opened trading at C$0.02.